Example: Heart Attack

Clinical Trials on Adenomyoepithelioma

Total 45 results

NCT04458597

Not yet recruiting

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

Conditions: Endometrioid Adenocarcinoma; Serous Carcinoma; Clear Cell Carcinoma; Carcinosarcoma; Dedifferentiated Carcinoma
NCT04227522

Not yet recruiting

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Clear Cell Carcinoma
NCT03602586

Suspended

Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer

Conditions: Malignant Ovarian Clear Cell Tumor; Recurrent Ovarian Carcinoma
NCT03466034

Terminated

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Conditions: Endometrial Cancer
NCT03405454

Recruiting

A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas

Conditions: Ovarian Clear Cell Carcinoma
NCT03355976

Recruiting

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Extra Renal Origin; Clear Cell Adenocarcinoma
NCT03348631

Suspended

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

Conditions: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; Recurrent Endometrial Endometrioid Adenocarcinoma; Recurrent Ovarian Carcinoma; Recurrent Ovarian Clear Cell Adenocarcinoma; Recurrent Ovarian Endometrioid Adenocarcinoma; Recurrent Uterine Corpus Cancer
NCT03297424

Recruiting

A Study of PLX2853 in Advanced Malignancies.

Conditions: Small Cell Lung Cancer; Uveal Melanoma; Ovarian Clear Cell Carcinoma; Non-Hodgkin Lymphoma; Advanced Malignancies; Solid Tumor; Diffuse Large B Cell Lymphoma; Follicular Lymphoma
NCT03241745

Recruiting

A Study of Nivolumab in Selected Uterine Cancer Patients

Conditions: Uterine Cancer; Endometrial Carcinoma; Carcinosarcoma; Leiomyosarcoma; Undifferentiated Sarcoma; High Grade Endometrial Stromal Sarcoma; Clear Cell Carcinoma
NCT03066427

Recruiting

Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.

Conditions: Clear Cell Renal Carcinoma
NCT02866370

Recruiting

Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium

Conditions: Ovarian Clear Cell Carcinoma; Endometrial Clear Cell Carcinoma
NCT02837991

Terminated

A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma

Conditions: Renal Cell Carcinoma (RCC); Clear-cell Renal Cell Carcinoma; Papillary Renal Cell Carcinoma; Kidney Neoplasms; Metastatic Renal Cell Carcinoma; Ovarian Clear Cell Carcinoma
NCT02819596

Unknown status

MEDI4736 Combinations in Metastatic Renal Cell Carcinoma

Conditions: Renal Clear Cell Carcinoma; Renal Papillary Cell Carcinoma
NCT02315430

Completed

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Conditions: Fallopian Tube Clear Cell Adenocarcinoma; Ovarian Clear Cell Adenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma
NCT02129036

Completed

Ovarian Clear Cell Adenocarcinoma Review

Conditions: Ovarian Cysts
NCT02059265

Active, not recruiting

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Conditions: Endometrial Clear Cell Adenocarcinoma; Ovarian Clear Cell Cystadenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Uterine Corpus Cancer
NCT01914510

Completed

A Study of ENMD-2076 in Ovarian Clear Cell Cancers

Conditions: Ovarian Clear Cell Carcinoma
NCT01824615

Completed

Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma

Conditions: Ovarian Cancer; Adverse Effects
NCT01732432

Withdrawn

Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)

Conditions: Endometrioid Carcinoma; Clear Cell Carcinoma; Endometriosis
NCT01672892

Active, not recruiting

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Conditions: Cervical Cancer; Endometrial Cancer; Gastrointestinal Complications; Perioperative/Postoperative Complications; Radiation Toxicity; Urinary Complications; Urinary Tract Toxicity
NCT01625351

Active, not recruiting

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Conditions: Ewing Sarcoma; Gastrointestinal Tumor; Germ Cell Tumor; Hepatic Tumor; Lymphoma; Wilms Tumor; Rhabdoid Tumor; Clear Cell Carcinoma; Renal Cell Carcinoma; Melanoma; Neuroblastoma; Rhabdomyosarcoma; Non-rhabdomyosarcoma
NCT01582204

Active, not recruiting

Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Conditions: Renal Cancer
NCT01196429

Completed

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Conditions: Ovarian Clear Cell Cystadenocarcinoma; Stage III Ovarian Cancer; Stage IV Ovarian Cancer
NCT01150682

Unknown status

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Conditions: Endometrial Cancer
NCT01100359

Unknown status

Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer

Conditions: Endometrial Cancer
NCT00853021

Completed

Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney

Conditions: Kidney Cancer
NCT00770185

Completed

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

Conditions: Endometrial Cancer
NCT00719264

Completed

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Conditions: Carcinoma; Adenocarcinoma; Renal Cell; Nephroid Carcinoma; Hypernephroid
NCT00563784

Completed

TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Conditions: Non-Small Cell Lung Cancer; Lung Cancer
NCT00467025

Completed

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Conditions: Advanced Renal Cell Carcinoma
NCT00455975

Completed

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Conditions: Renal Cancer; Kidney Cancer
NCT00448643

Completed

Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery

Conditions: Endometrial Cancer
NCT00416455

Completed

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Conditions: Cervical Adenocarcinoma; Cervical Adenosquamous Cell Carcinoma; Cervical Small Cell Carcinoma; Cervical Squamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Stage I Endometrial Carcinoma; Stage IB Cervical Cancer; Stage II Endometrial Carcinoma; Stage IIA Cervical Cancer; Stage IIB Cervical Cancer; Stage III Cervical Cancer; Stage III Endometrial Carcinoma; Stage IVA Cervical Cancer
NCT00411138

Active, not recruiting

Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer

Conditions: Endometrial Cancer
NCT00231829

Terminated

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Conditions: Uterine Cancer
NCT00131651

Terminated

ATN-161 in Advanced Renal Cell Cancer

Conditions: Carcinoma, Renal Cell
NCT00002493

Completed

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Conditions: Endometrial Cancer; Psychosocial Effects of Cancer and Its Treatment
NCT00003127

Completed

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Conditions: Endometrial Cancer
NCT00072176

Completed

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Conditions: Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial Carcinoma; Stage IIIA Endometrial Carcinoma; Stage IIIB Endometrial Carcinoma; Stage IIIC Endometrial Carcinoma; Stage IVA Endometrial Carcinoma; Stage IVB Endometrial Carcinoma
NCT00025467

Completed

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Conditions: Endometrial Adenoacanthoma; Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial Carcinoma
NCT00056537

Completed

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Conditions: Non-Small-Cell Lung Carcinoma; Renal Cell Carcinoma; Pancreatic Cancer
NCT00002807

Completed

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Conditions: Endometrial Cancer
NCT00003749

Completed

Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer

Conditions: Endometrial Cancer
NCT00005583

Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Conditions: Endometrial Cancer
NCT00006027

Completed

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

Conditions: Endometrial Cancer

Clinical Trials on Adenomyoepithelioma

Recent CRA jobs

Assoc Scientist- ICD

Associate Validation Analyst II

Project & Budget Coordinator/Analyst

Clinical Trial Coordinator - C (Italian/German/Spanish/French is advantage)

Senior Nurse Practitioner ; AES

Sr Project Manager - Vaccines Team (US Homebased)

Assoc Clinical Research Coord; AES

Medical Information Associate

QA Auditor I or QA Auditor II

Associate Marketing Manager / Marketing Manager